Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zepatier for HCV-negative heart transplant recipients
NCT03146741Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- May 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of grazoprevir in hepatitis C (HCV), sponsored by University of Pennsylvania. Started May 2017; status: completed.
02
Drugs
grazoprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03146741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03146741.